The International Journal of Tuberculosis and Lung Disease

Shortening MDR-TB treatment: is treating more patients with fewer drugs better?
pp. 419-420(2)
Authors: Akkerman, O. W.; Tiberi, S.; Alffenaar, J-W.

COVID-19 and TB: a progression-regression conundrum
pp. 421-423(3)
Authors: Teo, A. K. J.; Ong, C. W. M.; Hsu, L. Y.

TB and prisons: confinement does not contain the disease
pp. 424-426(3)
Authors: Tavoschi, L.; Toscanini, F.; Pontali, E.

A systematic review of the number needed to screen for active TB among people living with HIV
pp. 427-435(9)
Authors: Chaisson, L. H.; Naufal, F.; Delgado-Barroso, P.; Alvarez-Manzo, H. S.; Robsky, K. O.; Miller, C. R.; Golub, J. E.; Shapiro, A. E.

The impact of COVID-19 on TB: a review of the data
pp. 436-446(11)
Authors: McQuaid, C. F.; Vassall, A.; Cohen, T.; Fiekert, K.; COVID/TB Modelling Working Group *; White, R. G.

Interferon-gamma release assays for latent tuberculosis infection screening in Canadian federal correctional facilities
pp. 447-452(6)
Authors: Agostinis, A.; Heffernan, C.; Long, R.; Beckon, A.; Cockburn, S.; Ahmed, R.

Pretomanid with bedaquiline and linezolid for drug-resistant TB: a comparison of prospective cohorts
pp. 453-460(8)
Authors: Oelofse, S.; Esmail, A.; Diacon, A. H.; Conradie, F.; Olayanju, O.; Ngubane, N.; Howell, P.; Everitt, D.; Crook, A. M.; Mendel, C. M.; Wills, G. H.; Olugbosi, M.; del Parigi, A.; Sun, E.; Calatroni, A.; Spigelman, M.; Dheda, K.

Depression, stigma and quality of life in people with drug-susceptible TB and drug-resistant TB in Vietnam
pp. 461-467(7)
Authors: Redwood, L.; Mitchell, E. M. H.; Viney, K.; Snow, K.; Nguyen, T. A.; Dung, L. A. T.; Nguyen, V. N.; Fox, G. J.

Using a mobile application to improve pediatric presumptive TB identification in western Kenya
pp. 468-474(7)
Authors: Szkwarko, D.; Amisi, J. A.; Peterson, D.; Burudi, S.; Angala, P.; Carter, E. J.

Epidemiology and clinical characteristics of childhood TB identified using active and passive case finding
pp. 475-482(8)
Authors: Ikeda, S.; Cruz, A. T.; Starke, J. R.

Determinants of non-adherence to anti-TB treatment in high income, low TB incidence settings: a scoping review
pp. 483-490(8)
Authors: Jones, A. S. K.; Bidad, N.; Horne, R.; Stagg, H. R.; Wurie, F. B.; Kielmann, K.; Karat, A. S.; Kunst, H.; Campbell, C. N. J.; Darvell, M.; Clarke, A. L.; Lipman;, M. C. I.; on behalf of the IMPACT Study Group (NIHR 16/88/06)

The largest prison outbreak of TB in Western Europe investigated using whole-genome sequencing
pp. 491-497(7)
Authors: Roycroft, E.; Fitzgibbon, M. M.; Kelly, D. M.; Scully, M.; McLaughlin, A. M.; Flanagan, P. R.; Gordon, S. V.; Rogers, T. R.; Keane, J.; O´Meara, M.

Post-TB outcome science: a sub-discipline for TB survivorship studies?
pp. 498-501(4)
Author: Basham, C. A.

Dactylitis due to accidental needle-stick injury with a BCG-loaded syringe
pp. 502-504(3)
Authors: Chochliourou, E.; Pyrpasopoulou, A.; Gouridou, E.; Antachopoulos, C.; Roilides, E.

Airways flow limitation in symptomatic adult cannabis smokers
pp. 505-507(3)
Authors: Vozoris, N. T.; To, T. M.; Ryan, C. M.; Chow, C-W.

Financial incentives and dietary modification for TB patients
pp. 508-510(3)
Authors: Rajalakshmi, S.; Varma, R. P.

The absence of evidence of cure is not a risk for recurrent TB among patients treated for TB
pp. 511-512(2)
Authors: Mantshonyane, L.; Kgwaadira, B.; Gross, R.

Spatial distribution of TB among individuals with a history of incarceration
pp. 513-515(3)
Authors: Robsky, K. O.; Mukiibi, J.; Nalutaaya, A.; Kitonsa, P. J.; Isooba, D.; Nakasolya, O.; Baik, Y.; Kamoga, C. E.; Kendall, E. A.; Katamba, A.; Dowdy, D. W.

Alcohol use disorder and TB survivor health
pp. 516-517(2)
Authors: Basham, C. A.; Romanowski, K.; Johnston, J. C.

Dr Sistla Radhakrishna 1935–2020
pp. 518-518(1)
Author: Nunn, A.